Skip to Content

CREON 1224 (Creon 120,000 units amylase / 24,000 units lipase / 76,000 units protease)

Generic Name: pancrelipase

Pill with imprint CREON 1224 is Orange / Clear, Capsule-shape and has been identified as Creon 120,000 units amylase / 24,000 units lipase / 76,000 units protease. It is supplied by Solvay Pharmaceuticals Inc..

Creon is used in the treatment of chronic pancreatitis; pancreatic exocrine dysfunction; cystic fibrosis and belongs to the drug class digestive enzymes. Risk cannot be ruled out during pregnancy. Creon 120,000 units amylase / 24,000 units lipase / 76,000 units protease is not a controlled substance under the Controlled Substances Act (CSA).

Images for CREON 1224

Creon

Generic Name:
pancrelipase
Imprint:
CREON 1224
Strength:
120,000 units amylase / 24,000 units lipase / 76,000 units protease
Color:
Orange / Clear
Size:
11.00 mm
Shape:
Capsule-shape
Availability:
Rx and/or OTC
Drug Class:
Digestive enzymes
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Solvay Pharmaceuticals Inc.
Inactive Ingredients:
cetyl alcohol
dimethicone
triethyl citrate
hypromelloses
polyethylene glycol
Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide